Determination of androgen receptor degradation enhancer ASC-J9® in mouse sera and organs with liquid chromatography tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 88, Issue , 2014, Pages 117-122

  Soh, Shu Fang ^a,b   Huang, Chiung Kuei ^b   Lee, Soo Ok ^b   Xu, Defeng ^b   Yeh, Shuyuan ^b   Li, Jun ^a   Yong, Eu Leong ^a   Gong, Yinhan ^a   Chang, Chawnshang ^b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Androgen receptor; Distribution of drug; Liquid chromatography tandem mass spectrometry; Pharmacokinetics

Indexed keywords

ANDROGEN RECEPTOR; ASC J 9; ASC J9; CURCUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG HALF LIFE; HORMONE DETERMINATION; IN VIVO STUDY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY;

ANDROGEN RECEPTOR; ASC-J9(®); DISTRIBUTION OF DRUG; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; PHARMACOKINETICS;

ANDROGENS; ANIMALS; CALIBRATION; CELL PROLIFERATION; CHROMATOGRAPHY, LIQUID; CURCUMIN; HALF-LIFE; LIMIT OF DETECTION; LINEAR MODELS; LIVER; MALE; MICE; PROSTATE; RECEPTORS, ANDROGEN; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TESTIS; TISSUE DISTRIBUTION;

EID: 84884197033     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.08.020     Document Type: Article

References (17)

1. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Mol. Pharm. 2007, 4(6):807-818.
2. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Cancer Lett. 2008, 267:133-164.
3. Vareed S.K., Kakarala M., Ruffin M.T., Crowell J.A., Normolle D.P., Djuric Z., Brenner D.E. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1411-1417.
4. Adams B.K., Ferstl E.M., Davis M.C., Herold M., Kurtkaya S., Camalier R.F., Hollingshead M.G., Kaur G., Sausville E.A., Rickles F.R., Snyder J.P., Liotta D.C., Shojia M. Bioorg. Med. Chem. 2004, 12:3871-3883.
5. Saradhi U.V.R.V., Ling Y., Wang J., Chiu M., Schwartz E.B., Fuchs J.R., Chan K.K., Liu Z. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878(November (30)):3045-3051.
6. Wei X., Du Z.Y., Zheng X., Cui X.X., Conney A.H., Zhang K. Eur. J. Med. Chem. 2012, 53:235-245.
7. Singh S.P., Wahajuddin, Jain G.K. J. Bioanal. Biomed. 2011, 2:79-84.
8. Li R., Qiao X., Li Q., He R., Ye M., Xiang C., Lin X., Guo D. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 879:2751-2758.
9. Tamvakopoulos C., Dimas K., Sofianos Z.D., Hatziantoniou S., Han Z., Liu Z.L., Wyche J.H., Pantazis P. Clin. Cancer Res. 2007, 13:1269-1277.
10. Yamashita S., Lai K.P., Chuang K.L., Xu D., Miyamoto H., Tochigi T., Pang S.T., Li L., Arai Y., Kung H.J., Yeh S., Chang C. Neoplasia 2012, 14(1):74-83.
11. Lai K.P., Huang C.K., Chang Y.J., Chung C.Y., Yamashita S., Li L., Lee S.O., Yeh S., Chang C. Am. J. Pathol. 2013, 182(February (2)):460-473.
12. Wu M.H., Ma W.L., Hsu C.L., Chen Y.L., Ou J.H., Ryan C.K., Hung Y.C., Yeh S., Chang C. Sci. Transl. Med. 2010, 2(May (32)):32-35.
13. Miyamoto H., Yang Z., Chen Y.T., Ishiguro H., Uemura H., Kubota Y., Hu Y.C., Tsai M.Y., Yeh S., Messing E.M., Chang C. J. Natl. Cancer Inst. 2007, 99:558-568.
14. Yang Z., Chang Y.J., Yu I.C., Yeh S., Wu C.C., Miyamoto H., Merry D.E., Sobue G., Chen L.M., Chang S.S., Chang C. Nat. Med. 2007, 13(March (3)):348-353.
15. Lin T.H., Izumi K., Lee S.O., Lin W.J., Yeh S., Chang C. Cell Death Dis. 2013, 4:e764. 10.1038/cddis/2013.270.
16. Lin T.H., Niu Y., Lee S.O., Xu D., Liang L., Li L., Yeh S.D., Fujimoto N., Yeh S., Chang C. J. Biol. Chem. 2013, 288(July (27)):19359-19369.
17. Guidance for Industry Bioanalytical Method Validation, available from website. http://www.fda.gov/cder/guidance/4252fnl.pdf.